First Interstate Bank bought a new stake in Envision Healthcare Corporation (NYSE:EVHC) during the first quarter, according to its most recent 13F filing with the SEC. The fund bought 3,000 shares of the company’s stock, valued at approximately $184,000.

A number of other large investors have also made changes to their positions in EVHC. Frontier Capital Management Co. LLC increased its stake in shares of Envision Healthcare Corporation by 65.2% in the fourth quarter. Frontier Capital Management Co. LLC now owns 249,842 shares of the company’s stock valued at $15,813,000 after buying an additional 98,564 shares during the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Envision Healthcare Corporation during the fourth quarter valued at $2,527,000. Water Island Capital LLC acquired a new stake in shares of Envision Healthcare Corporation during the third quarter valued at $8,496,000. 1832 Asset Management L.P. increased its stake in shares of Envision Healthcare Corporation by 43.8% in the third quarter. 1832 Asset Management L.P. now owns 451,894 shares of the company’s stock valued at $10,063,000 after buying an additional 137,658 shares during the last quarter. Finally, Blackstone Group L.P. increased its stake in shares of Envision Healthcare Corporation by 326.4% in the third quarter. Blackstone Group L.P. now owns 496,055 shares of the company’s stock valued at $11,047,000 after buying an additional 379,711 shares during the last quarter. 67.47% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Envision Healthcare Corporation (NYSE EVHC) opened at 58.63 on Friday. Envision Healthcare Corporation has a one year low of $53.12 and a one year high of $81.26. The firm’s market cap is $6.81 billion. The stock has a 50 day moving average of $56.31 and a 200 day moving average of $63.22.

Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings results on Tuesday, May 2nd. The company reported $0.69 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.69. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $2.52 billion. Envision Healthcare Corporation had a positive return on equity of 5.75% and a negative net margin of 9.16%. On average, equities analysts forecast that Envision Healthcare Corporation will post $1.40 earnings per share for the current year.

WARNING: This piece was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/06/17/first-interstate-bank-invests-184000-in-envision-healthcare-co-evhc-updated-updated.html.

Several brokerages recently weighed in on EVHC. Jefferies Group LLC reaffirmed a “buy” rating and set a $82.00 target price (down from $90.00) on shares of Envision Healthcare Corporation in a research note on Wednesday, March 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $80.00 target price (down from $87.00) on shares of Envision Healthcare Corporation in a research note on Wednesday, March 1st. TheStreet downgraded shares of Envision Healthcare Corporation from a “b-” rating to a “c+” rating in a research note on Thursday, March 9th. Zacks Investment Research downgraded shares of Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, March 7th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Envision Healthcare Corporation in a research note on Thursday, March 16th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Envision Healthcare Corporation presently has a consensus rating of “Buy” and a consensus price target of $72.00.

In other Envision Healthcare Corporation news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare Corporation stock in a transaction on Wednesday, May 3rd. The stock was sold at an average price of $60.53, for a total value of $90,795.00. Following the completion of the transaction, the insider now directly owns 114,363 shares of the company’s stock, valued at approximately $6,922,392.39. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 3.10% of the company’s stock.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.